Monitoring and screening programs for patients with familial hypercholesterolemia

Authors

  • U. V. Chubykina National Medical Research Center of Cardiology of the Ministry of Healthcare of Russia
  • O. I. Afanasyeva National Medical Research Center of Cardiology of the Ministry of Healthcare of Russia
  • N. A. Tmoyan National Medical Research Center of Cardiology of the Ministry of Healthcare of Russia
  • M. V. Ezhov National Medical Research Center of Cardiology of the Ministry of Healthcare of Russia

DOI:

https://doi.org/10.34687/2219-8202.JAD.2020.02.0006

Keywords:

familial hypercholesterolemia, cascade screening, opportunistic screening, universal screening, targeted screening, lipid centers, register of familial hypercholesterolemia, lipoprotein(a)

Abstract

Familial hypercholesterolemia is the most common monogenic disease associated with the premature development of coronary heart disease. Awareness of the effectiveness, significance, and availability of screening programs aimed at identifying index patients and their relatives with familial hypercholesterolemia can lead to a significant decrease in the burden of cardiovascular disease. Early detection, initiation of adequate lipid-lowering therapy and monitoring of patients with familial hypercholesterolemia based on lipid centers will lead to decrease in mortality and disability from cardiovascular diseases.

Downloads

Download data is not yet available.

Published

2020-06-24

How to Cite

Chubykina U. V., Afanasyeva O. I., Tmoyan N. A., Ezhov M. V. Monitoring and screening programs for patients with familial hypercholesterolemia // The Journal of Atherosclerosis and Dyslipidemias. 2020. VOL. № 2 (39). PP. 43–48.

Issue

Section

Original research paper

Most read articles by the same author(s)

1 2 3 4 > >>